After the baptism of the epidemic situation, the UD-Bio Lingmu series of thrombus elasticity chart instrument and the complete range of reagents have been widely used and highly recognized in the top three hospitals in more than 20 provinces and municipalities across the country.
More than one hundred new installations have also been received by the majority of agents and partners.
Zibo Women's and Children's Hospital is also the Third People's Hospital of Zibo City (Third Class A). UD-Bio engineers are training the operation of thrombus elasticity charter UD-T5000 for transfusionists.
UD-Bio UD-T5000 thrombus elasticity chart instrument + reagent, stationed in Hebi City People's Hospital of Henan Province (top three), has excellent consistency with imported brands on-site comparison, and has been highly recognized by customers.
The Department of Blood Transfusion of the Affiliated Hospital of Hangzhou Normal University (Third Class A) strongly introduced the UD-T5000, a UD-Bio thromboelastography.
UD-T5000 was introduced in the laboratory of Wangdu County People's Hospital in Hebei Province.
Zhengzhou Renji Hospital purchased an UD-T5000 UD-T5000 in April 2019. A year of clinical use doctors felt the machine’s convenient operation and accurate inspection. Two new UD-T5000s were purchased in April this year. Customers' repeated purchases represent the trust of customers and agents in UD-Bio.
During the epidemic, in order to respond to the needs of agents around the world and provide customized services for agents, UDI formed an academic application promotion team to actively carry out online and offline sharing sessions. The outbreak did not hinder the pace of UDI academic sharing and training services.
The UD-Bio Academic Application Promotion Team has organized more than 100 online live webcasts from January to May, and shared the front-end technology and clinical operation counseling of UD-Bio Thrombus and Coagulation with more than 1,000 industry colleagues across the country; and actively organized offline The on-site sharing meeting will further introduce Youdi technology products, services, and after-sale training on installation and use.
UD-Bio cost-effective thrombus and coagulation products and matching reagents, simple clinical operation, accurate test results, 7*24 hours online service, perfect and fast after-sales service, and technology sharing and service support The innovative model has made every agent partner more confident.
In this sudden new epidemic epidemic battle "epidemic", UD-Bio Ling eye series thrombus elasticity chart instrument shows its talents to help doctors more fully observe the dynamic changes of patients' coagulation function. Generally speaking, nearly 20% of COVID-19 patients will have abnormal coagulation function. Almost all severe and critically ill patients have coagulation dysfunction. COVID-19 patients regularly review the coagulation index to prevent the occurrence of thrombosis and bleeding events. important. Because the thromboelastography instrument can dynamically monitor coagulation factors, fibrinogen, platelet function and other indicators and comprehensively judge the risk of bleeding and thrombosis in patients, early prevention and treatment can be achieved in the prevention and treatment of new crown epidemics. After the epidemic, the thromboelastography instrument can still be used as a diagnosis "assistant" in the transfusion department, helping doctors understand the patient's coagulation picture, quickly determine the coagulation function, identify the cause of coagulation abnormalities, guide blood transfusion, monitor anticoagulant drugs, and check the risk of thrombosis , So as to achieve the contrarian growth of sales.
Soon, the UD-T8000 eight-channel thromboelastograph UD-T8000, which is highly anticipated by national agents, will be launched soon. High-throughput and highly automated will meet the needs of a large number of clinical specimen processing and avoid the risk of specimen contamination caused by manual operation! Sharing advanced technology and working together sincerely, UD-Bio and its agents grow together. Rather than selling products, UD-Bio is looking for and nurturing more partners to promote the rapid development of the coagulation diagnostic industry.
